Genmab A (GMAB) Treasury Shares (2018 - 2025)

Genmab A (GMAB) has reported Treasury Shares for 6 consecutive years, with $2.6 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 963.57% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 million (up 963.57% YoY), and the FY2025 full-year result was $2.6 million, up 963.57% from the prior year.
• Treasury Shares improved to $2.6 million in Q4 2025 per GMAB's latest filing, from $246283.6 in the prior quarter.
• Across five years, Treasury Shares topped out at $2.6 million in Q4 2025 and bottomed at -$15.5 billion in Q4 2021.
• Historically, Treasury Shares has averaged -$5.2 billion across 3 years, with a median of $246283.6 in 2024.
• The sharpest annual moves came in 2021 and 2025: Treasury Shares grew 18.74% in 2021, then jumped 963.57% in 2025.
• Over 3 years, Treasury Shares stood at -$15.5 billion in 2021, then jumped by 100.0% to $246283.6 in 2024, then surged by 963.57% to $2.6 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.6 million, $246283.6, and -$15.5 billion for Q4 2025, Q4 2024, and Q4 2021 respectively.